Regulation of DNA Replication by MCM Proteins
MCM 蛋白对 DNA 复制的调节
基本信息
- 批准号:7582247
- 负责人:
- 金额:$ 32.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseATR protein kinaseAbbreviationsAddressAphidicolinBindingBinding ProteinsBypassCDC7 geneCell NucleusCellsChromatinChromatin StructureChromosomesComb animal structureComplexDNADNA DamageDNA Polymerase InhibitorDNA biosynthesisDNA replication forkDNA-Directed DNA PolymeraseDataDiseaseDown-RegulationEmployee StrikesEventG1 PhaseGenerationsGeneticGenetic MaterialsGenomeGenome StabilityGenomic InstabilityHistone DeacetylaseIn VitroLifeMCM2 geneMOS pp39 Serine/Threonine KinaseMYC geneMaintenanceMalignant NeoplasmsMethanobacteriaMethanobacteriumMutationOncogene ActivationOncogenesOutputPhasePhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPlayPre-Replication ComplexProcessPrognostic MarkerProtein KinaseProteinsProto-OncogenesRecombinantsRecruitment ActivityRegulationReplication InitiationReplication OriginRiskRoleSingle-Stranded DNASiteSourceStressSystemTestingTherapeutic InterventionTimeTo specifyataxia telangiectasia mutated proteinhelicasehistone acetyltransferasehuman CDC7 proteininsightnovelorigin recognition complexoverexpressionprotein complexprotein functionresponsetransmission processtumortumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Regulation of DNA replication initiation and fork progression is critical for the maintenance of genome stability. The mini-chromosome maintenance (MCM) proteins are uniquely required for pre-replicative complex (pre-RC) assembly, origin firing and replisome progression. Because all MCM proteins are essential for life, their role and mechanism of action beyond pre-RC assembly has been difficult to assess. We have purified active recombinant MCM complexes that support all known MCM functions associated with DNA replication in MCM- depleted cell-free extracts. This system allows us to bypass the experimental limitation associated with MCM's essential roles. MCM are connected with the maintenance of genome stability in several ways. MCM proteins are targets of the ATM/ATR kinases, down-regulation of MCM protein levels triggers genome instability and increased origin activity by the MCM-binding protein Myc, activates a DNA damage response, generates damage and genome instability. Finally, MCM are aberrantly expressed in a variety of tumor and are used as prognostic markers for tumor progression. First, we will investigate two key aspects of MCM activity: the mechanism of DNA unwinding and the regulation of MCM unloading from chromatin. Phosphorylation of the MCM complex by CDC7 protein kinase is an essential step in the activation of origins. Next, we want to characterize these phosphorylation events and assess their physiological consequences. A striking feature of initiation of DNA replication is that a vast excess of MCM complexes are loaded on chromatin and only a subset of these potential sites of DNA unwinding is specified to become functional origins of replication. We have determined that the Myc proto-oncogene binds to MCM proteins and plays a role in origin specification. We propose to characterize this novel function of Myc. We will also investigate the potential role of MCM complexes that have not been specified to be functional origins, in replication restart. Finally, we will probe further the role of MCM in the maintenance of genome stability by analyzing how down-regulation of MCM proteins or unscheduled activation of replication origins generates DNA damage. We will also determine the contribution of MCM phosphorylation by the ATM and ATR protein kinase to the maintenance of genome stability during DNA replication. We anticipate that these studies will provide important insights into the mechanism of MCM proteins functions. In particular, probing the connection between MCM, Myc and the maintenance of genome stability during S-phase will be critical to identify targets for therapeutic intervention in cancer associated with oncogene activation and replication stress.
Cancer can be viewed as a disease of genome instability. The most challenging time for a cell to maintain genome stability is during DNA replication, when complex DNA transactions put the integrity of the genome at risk. The focus of this proposal is the MCM proteins, which are required throughout DNA replication and critical for the maintenance of genome stability under normal conditions or following oncogene-dependent, replication stress.
描述(由申请人提供):DNA复制起始和叉进程的调节对于维持基因组稳定性至关重要。微型染色体维持(MCM)蛋白是重复的复合物(PRE-RC)组装,起源射击和重新分散进程所必需的。由于所有MCM蛋白对于生命都是必不可少的,因此很难评估它们以外的RC组装以外的作用和作用机制。我们已经纯化了活跃的重组MCM复合物,该复合物支持与MCM耗尽无细胞提取物中与DNA复制相关的所有已知MCM功能。该系统使我们能够绕过与MCM基本角色相关的实验限制。 MCM通过多种方式与基因组稳定性保持联系。 MCM蛋白是ATM/ATR激酶的靶标,MCM蛋白水平的下调会触发基因组不稳定性,而MCM结合蛋白MYC的起源活性增加,激活了DNA损伤反应,会产生损伤和基因组不稳定性。最后,MCM在多种肿瘤中异常表达,并用作肿瘤进展的预后标记。首先,我们将研究MCM活性的两个关键方面:DNA的机理以及从染色质中卸载MCM的调节。 CDC7蛋白激酶对MCM复合物的磷酸化是起源激活的重要步骤。接下来,我们要表征这些磷酸化事件并评估其生理后果。 DNA复制启动的一个惊人特征是,在染色质上加载了大量的MCM复合物,只有DNA放松的这些潜在位点的子集被指定为复制的功能起源。我们已经确定MYC原始癌基因与MCM蛋白结合并在原点规范中起作用。我们建议表征MYC的新功能。我们还将研究尚未指定为功能起源的MCM复合物在复制重新启动中的潜在作用。最后,我们将通过分析MCM蛋白的下调或外部复制起源的下调如何产生DNA损伤来进一步探讨MCM在维持基因组稳定性中的作用。我们还将确定ATM和ATR蛋白激酶对DNA复制过程中基因组稳定性维持的MCM磷酸化的贡献。我们预计这些研究将为MCM蛋白功能的机理提供重要的见解。特别是,探测S相过程中MCM,MYC和基因组稳定性维持之间的联系对于确定与癌基因激活和复制应力相关的癌症治疗干预靶标至关重要。
癌症可以看作是基因组不稳定性疾病。细胞保持基因组稳定性的最具挑战性时间是在DNA复制期间,当复杂的DNA交易使基因组的完整性处于危险之中时。该提案的重点是MCM蛋白,这在整个DNA复制过程中都是必需的,对于在正常条件下或遵循致癌基因依赖性的复制应力下维持基因组稳定性至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEAN GAUTIER其他文献
JEAN GAUTIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEAN GAUTIER', 18)}}的其他基金
DNA Repair and Genomic Instability in Cancer Development and Therapy
癌症发展和治疗中的 DNA 修复和基因组不稳定性
- 批准号:
10221625 - 财政年份:2015
- 资助金额:
$ 32.2万 - 项目类别:
DNA Repair and Genomic Instability in Cancer Development and Therapy
癌症发展和治疗中的 DNA 修复和基因组不稳定性
- 批准号:
9322608 - 财政年份:2015
- 资助金额:
$ 32.2万 - 项目类别:
DNA Repair and Genomic Instability in Cancer Development and Therapy
癌症发展和治疗中的 DNA 修复和基因组不稳定性
- 批准号:
9979776 - 财政年份:2015
- 资助金额:
$ 32.2万 - 项目类别:
DNA Repair and Genomic Instability in Cancer Development and Therapy
癌症发展和治疗中的 DNA 修复和基因组不稳定性
- 批准号:
8955897 - 财政年份:2015
- 资助金额:
$ 32.2万 - 项目类别:
DNA Repair and Genomic Instability in Cancer Development and Therapy
癌症发展和治疗中的 DNA 修复和基因组不稳定性
- 批准号:
9117526 - 财政年份:2015
- 资助金额:
$ 32.2万 - 项目类别:
DNA double-strand break repair, chromosome translocations and cancer
DNA双链断裂修复、染色体易位和癌症
- 批准号:
10394193 - 财政年份:2014
- 资助金额:
$ 32.2万 - 项目类别:
DNA double-strand break repair, chromosomes translocations and cancer
DNA 双链断裂修复、染色体易位和癌症
- 批准号:
8835071 - 财政年份:2014
- 资助金额:
$ 32.2万 - 项目类别:
DNA double-strand break repair, chromosomes translocations and cancer
DNA 双链断裂修复、染色体易位和癌症
- 批准号:
9241973 - 财政年份:2014
- 资助金额:
$ 32.2万 - 项目类别:
相似海外基金
Regulation of DNA Replication by MCM Proteins
MCM 蛋白对 DNA 复制的调节
- 批准号:
7883024 - 财政年份:2009
- 资助金额:
$ 32.2万 - 项目类别:
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
RAD18 和 POLZ 影响抗癌药物反应的新机制
- 批准号:
7759548 - 财政年份:2008
- 资助金额:
$ 32.2万 - 项目类别:
Regulation of DNA Replication by MCM Proteins
MCM 蛋白对 DNA 复制的调节
- 批准号:
7384287 - 财政年份:2008
- 资助金额:
$ 32.2万 - 项目类别:
Regulation of DNA Replication by MCM Proteins
MCM 蛋白对 DNA 复制的调节
- 批准号:
7782677 - 财政年份:2008
- 资助金额:
$ 32.2万 - 项目类别:
Regulation of DNA Replication by MCM Proteins
MCM 蛋白对 DNA 复制的调节
- 批准号:
8050089 - 财政年份:2008
- 资助金额:
$ 32.2万 - 项目类别: